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ABSTRACT
Background: Due to the potential risk of iron supple-
mentation in iron replete children, it is important to
properly identify children who may require iron supple-
mentation. However, assessment of the iron status has
proven to be difficult, especially in children living in areas
with high infection pressure (including malaria).
Aims and Methods: Biochemical iron markers were
compared to bone marrow iron findings in 381 Malawian
children with severe anaemia.
Results: Soluble transferrin receptor/log ferritin (TfR-F
index), using a cut-off of 5.6, best predicted bone marrow
iron stores deficiency (sensitivity 74%, specificity 73%,
accuracy 73%). In order to improve the diagnostic
accuracy of ferritin or sTfR as a stand-alone marker, the
normal cut-off value needed to be increased by 810% and
83% respectively. Mean cell haemoglobin concentration
(MCHC), using a cut-off of 32.1 g/dl, had a sensitivity of
67% and specificity of 64% for detecting iron stores
deficiency.
Conclusion: TfR-F index incorporated the high sensitivity
of sTfR, a proxy for cellular iron need, and the high
specificity of ferritin, a proxy for iron stores. In areas with
a high infection pressure, the TfR-F index best predicted
iron deficiency. However, in settings where diagnostic
tests are limited, MCHC may be an acceptable alternative
screening test.
The examination of stained aspirates of bone
marrow for haemosiderin has been considered the
‘‘gold standard’’ as a method for evaluation of iron
status.
1 This technique is invasive and therefore
not suitable for screening. There are currently
several laboratory assays available for assessing the
iron status in children. These are widely used in
clinics and include ferritin, serum iron, serum
transferrin, total iron binding capacity (TIBC)
and mean cell volume (MCV). However, these
iron markers are considerably altered by inflamma-
tion, which limits their applicability, especially in
areas with a high infection pressure. Surprisingly, it
is still unclear to what extent adjustment of the
recommended cut-off values for these iron markers
is required in order to improve their diagnostic
efficiency. To date there are no studies which have
validated these iron markers against the ‘‘gold
standard’’ (bone marrow iron content) in children
living in areas endemic for malaria and other
common infective conditions. In areas with a
limited infection pressure, soluble transferrin
receptor (sTfR) has been shown to be a promising
new tool for the diagnosis of deficiency of iron
stores.
2
Due to a recent finding in Tanzania of an
increased mortality in iron replete children receiv-
ing iron supplementation, there is an urgent need
to be able to target iron therapy and prophylaxis
programmes on the children with proven iron
deficiency.
3 To be able to do this there is a need for
non-invasive and sensitive tests that distinguish
iron stores deficiency from functional iron defi-
ciency which is associated with anaemia of
inflammation. We have evaluated the diagnostic
accuracy of various iron markers against bone
marrow iron assessment in children residing in an
area of high infection pressure.
METHODS
This study formed part of a large case–control
study investigating the aetiology of severe anaemia
among Malawian children described in detail
elsewhere.
4 In summary, the study was conducted
between July 2002 and July 2004 in malaria
endemic areas of Blantyre and Chikwawa.
Children aged 6–59 months, presenting to hospital
with severe anaemia (Hb ,5 g/dl) were enrolled as
cases. Written informed consent was obtained
from the guardians of the children, and the study
was approved by the ethics committees of the
University of Malawi and the Liverpool School of
Tropical Medicine, UK.
Clinical assessment and management
Children had a detailed medical examination
performed before collecting a sample of venous
blood. Under local anaesthesia, a bone marrow
aspiration was performed from the anterior or
posterior iliac crest. All bone marrows were
performed in the presence of the child’s guardian
and she/he was allowed to withdraw consent at
any time during the procedure. All children
received a blood transfusion and were managed
according to standard hospital protocols.
4
Laboratory methods
On recruitment, haematological indices (including
haemoglobin (Hb), mean cell volume (MCV) and
meancellhaemoglobinconcentration(MCHC))were
determined using the HemoCue B-Haemoglobin
(HemoCue AB, A ¨ngelholm, Sweden) and a coulter
counter analyser (Beckman Coulter, Durban, South
Africa). Ferritin, serum iron and serum transferrin
were also assayed (Roche Diagnostics, Switzerland).
sTfR was measured using an enzyme immunoassay
(Ramco Laboratories, Texas, USA). Blood was cul-
tured for 5 and 56 days for the presence of routine
pathogens and mycobacteria, respectively, using an
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Missouri, USA).
Definitions and cut-off values
Malaria was defined as presence of Plasmodium falciparum
asexual parasites in blood. HIV testing was done using two
rapid tests according to WHO guidelines and discordant results
were resolved by PCR.
5
Internationally accepted cut-off values for biochemical iron
markers used in this analysis were as follows: ferritin ,30 mg/l
6;
serum iron ,3.6 mmol/l; serum transferrin .3.6 g/l; TIBC .
72 mmol/l (laboratory reference values); transferrin saturation
,16%
6;s T f R.8.3 mg/l (test kit reference value); MCV ,67 fl
(,2 years old) and ,73 fl (2–5 years old); MCHC ,32 g/l.
6
Transferrin-ferritin (TfR-F) index was defined as [sTfR 4 log
ferritin].
7ATfR-Findexvalueof.5.6(usingsTfRof.8.3 mg/land
ferritinof,30 mg/l)wasusedtodefinedeficiencyofironstores.
8C-
reactive protein (CRP) of .10 mg/ml was defined as increased.
9
Bone marrow aspirates were prepared and stained using a
commercial kit and according to manufacturer guidelines
(HematoGnost Fe, Darmstadt, Germany). Smears were graded
for iron and defined as positive when the fragment iron was
,2.
8 Bone marrow iron assessment was used as the gold
standard for diagnosis of iron stores deficiency.
Statistical analysis for sensitivity, specificity, positive pre-
dictive value (PPV), negative predictive value (NPV) and
accuracy for individual iron markers was calculated using
SPSS V.11.0. Iron markers having either a sensitivity or
specificity ,20% were classified as poor predictors of iron
stores deficiency and were dropped from further analysis. For
the remaining iron markers, receiver operating characteristics
(ROC) curves for identifying the optimal cut-offs for best
identifying iron stores deficiency were constructed, and the
corresponding areas under the curve (AUC
ROC) for all the
markers were compared. A new cut-off for each iron marker
which provided maximal sensitivity and specificity was
determined from ROC curves.
10 KSP analysed the data but all
others had access to the primary dataset.
RESULTS
A total of 381 children were recruited with an average age of 1.7
years (SD 1.1); 46.7% (178/381) were male (table 1). Sixty per
cent of severely anaemic children had malaria parasites in their
blood; CRP was raised in 89%. Ferritin levels were increased,
with a mean concentration of 729.2 (1528.1) mg/l (table 2). The
proportions of children that were iron deficient ranged from 1%
using TIBC to 97.5% using serum transferrin.
Table 3 shows sensitivity and specificity of various iron
markers. Poor markers that were dropped from further analysis
included serum transferrin, TIBC and MCV, which had a
sensitivity of 0%, 0% and 4% (,2 years) and 17% (>2 years),
respectively. Ferritin, serum iron and transferrin saturation had
Table 1 Baseline characteristics of cases
Characteristic Result
Recruited n=381
Age (months)* 20.4 (12.8) [381]
Hb (g/dl)* 3.6 (0.8) [381]
CRP (mg/ml)* 11.1 (8.5) [346]
Male 178/381 (46.7%)
Wasted{ 52/330 (15.8%)
Stunted{ 176/331 (53.2%)
Malaria 226/380 (59.5%)
HIV 33/345 (9.6%)
Bacteraemia 52/259 (20.1%)
*Mean (SD) [total number].
{Z-score ,22 weight-for-height.
{Z-score ,22 height-for-age.
CRP, C-reactive protein; Hb, haemoglobin.
Table 2 Mean iron marker and the proportion of children classified as
iron stores deficient using internationally accepted cut-off values
Iron marker Mean (SD) Normal levels
Proportion iron
deficient (%)
Ferritin (mg/l) 729.2 (1528.1) 30–300 12.7
sTfR (mg/ml) 17.4 (15.8) ,8.3 73.2
TfR-F index 12.9 (28.1) ,5.6 46.4
Serum iron (mmol/l) 16.0 (15.7) 3.6–27.0 19.8
Serum transferrin (g/l) 2.2 (0.7) 2.0–3.6 2.5
Transferrin saturation (%) 41.4 (39.7) .16 37.4
TIBC (mmol/l) 41.5 (12.7) ,72 1.0
MCHC (g/dl) 32.9 (7.8) 32.0–36.8 43.3
MCV (fl)
,2 years 106.3 (81.4) 67–91 12.1
>2 years 117.7 (88.1) 73–89 21.5
MCHC, mean cell haemoglobin concentration; MCV, mean cell volume; sTfR, soluble
transferrin receptor; TfR-F index, transferrin-ferritin index; TIBC, total iron binding
capacity.
Table 3 Sensitivity and specificity of iron markers to identify children with iron stores deficiency using
internationally accepted cut-off values and bone marrow iron as the ‘‘gold standard’’
True False
Sensitivity Specificity Accuracy Positives Negatives Positives Negatives
Ferritin 5 76 3 19 21 96 79
sTfR 35 52 87 4 90 37 49
TfR-F index 16 55 18 7 70 75 74
Serum iron 7 93 13 22 24 88 74
Serum transferrin 0 127 0 33 0 100 79
Transferrin
Saturation
10 80 26 19 35 76 67
TIBC 0 127 0 33 0 100 79
MCHC 22 81 40 13 63 67 66
MCV
,2 years 1 71 8 22 4 90 71
>2 years 2 36 7 10 17 84 69
AUC, area under the curve; MCHC, mean cell haemoglobin concentration; MCV, mean cell volume; ROC, receiver operating
characteristics; sTfR, soluble transferrin receptor; TfR-F index, transferrin-ferritin index; TIBC, total iron binding capacity.
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had a high sensitivity of 90% and low specificity of 37%. The
accuracy of a marker was highest for ferritin (79%) and lowest
for sTfR (49%).
ROC curves for defining the optimal cut for the identification
of deficiency of iron stores for ferritin, sTfR, TfR-F index, and
other iron markers were constructed (fig 1). The area under the
curve (AUC
ROC) for each marker represented their performance
(table 4). Ferritin, sTfR, TfR-F index and MCHC had
significantly higher AUC
ROC than 0.5, where 0.5 signified an
ineffective test. Serum iron and transferrin saturation were
excluded from further analysis as they had non-significant
AUC
ROC (0.62 and 0.60, respectively).
For the remaining iron markers, ferritin, sTfR, TfR-F index
and MCHC, new cut-off levels, with an optimal combination of
sensitivity and specificity, were determined from the ROC
curves. Table 5 shows the resultant sensitivity and specificity,
and the percentage change from the original cut-off. The ability
of sTfR or ferritin to predict iron stores deficiency (accuracy)
was similar and above 75% using the derived cut-offs of 273 mg/l
and 15.2 mg/ml, respectively. Although the sensitivity and
specificity for TfR-F index or MCHC (sensitivity 74%, 67%;
and specificity 73%, 64%, respectively) were lower than those
for ferritin and sTfR, they required smaller changes from their
original to new cut-off levels.
DISCUSSION
Inthepresentstudy,thediagnosticefficiencyofsTfRandavariety
of more conventional laboratory tests for the identification of
deficiency of iron stores or functional deficiency was evaluated.
The results suggested that serum transferrin, TIBC and transferrin
saturation were of limited value in diagnosis of deficiency of iron
stores as their corresponding AUC
ROC values did not provide
acceptable sensitivity and specificity estimates. Most likely, this
relates to the interference of inflammatory cytokines produced as
part of the acute phase response during an infection.
11 12
The bone marrow iron smear was used as the ‘‘gold standard’’
for the diagnosis of deficiency of iron stores. It has generally
been considered the most reliable diagnostic test, but has the
limitations of being more invasive than peripheral blood iron
markers.
1 Furthermore, incorrect assessment of iron stores in
bone marrow aspirates has been described.
13
Ferritin has been widely used as an iron marker in individuals
without inflammatory conditions.
6 Conversely, sTfR is con-
sidered to reflect the degree of tissue iron need, and there is
evidence that it is a good indicator of iron status when the iron
stores are depleted.
14 The reciprocal relationship between sTfR
and ferritin describes a perfect log-linear relationship over a
wide range of normal and depleted iron stores states. Punnonen
et al
7 evaluated various possibilities of combinations of sTfR and
ferritin parameters, and concluded that use of the sTfR/log
ferritin ratio (TfR-F index) considerably improved diagnostic
efficiency, even in settings with a high infection pressure.
In the present study, serum ferritin had a high specificity and
sTfR a high sensitivity, which is consistent with previous
studies.
15 Changing the current conventional cut-off of TfR-F
index (5.6) to its optimal cut-off (according to the ROC
analysis) of 5.3 has little effect on its diagnostic efficiency. This
is in contrast with ferritin and sTfR which required a change of
810% and 80%, respectively, to achieve maximal sensitivity and
specificity.
During a study in which healthy volunteers were serially
phlebotomised to induce iron deficiency, MCHC was found to
be a sensitive early indicator of iron deficient erythropoiesis.
16 17
In the present study, MCHC had a relatively good diagnostic
efficiency. This is relatively good news since MCHC can be
measured using a coulter counter, which is relatively cheap and
Figure 1 Received operating characteristic curves of soluble transferrin
receptor (sTfR), ferritin and transferrin-ferritin index (TfR-F index) in the
identification of iron stores deficiency. MCHC, mean cell haemoglobin
concentration.
Table 4 AUC
ROC values for biochemical iron markers to identify children
with deficiency of iron stores based on new cut-off values
AUC
ROC SE p Value
Ferritin 0.82 0.05 ,0.001
sTfR 0.80 0.04 ,0.001
TfR-F index 0.79 0.06 ,0.001
Serum iron 0.58 0.06 0.2
Transferrin saturation 0.57 0.06 0.3
TIBC 0.52 0.06 0.8
MCHC 0.68 0.06 0.001
AUC, area under the curve; MCHC, mean cell haemoglobin concentration; ROC,
receiver operating characteristics; sTfR, soluble transferrin receptor; TfR-F index,
transferrin-ferritin index; TIBC, total iron binding capacity.
Table 5 Ability of ferritin, sTfR, TfR-F index and MCHC to identify children with deficiency of iron stores
based on new cut-off values
Original cut-off New cut-off
% change in
cut-off Sensitivity* Specificity* Accuracy*
Ferritin 30 mg/l 273 mg/l 810 75 76 76
sTfR 8.3 mg/ml 15.2 mg/ml 83 77 76 76
TfR-F index 5.6 5.3 257 4 7 3 7 3
MCHC 32.0 g/l 32.1 g/l 0.3 67 64 65
*Sensitivity, specificity or accuracy of new cut-off.
MCHC, mean cell haemoglobin concentration; sTfR, soluble transferrin receptor; TfR-F index, transferrin-ferritin index.
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with either ferritin or sTfR.
Results from the present study suggest that it is necessary to
change the cut-off limit for ferritin from 30 to 273 mg/l in order
to improve its diagnostic efficiency. This proposed increase is
consistent with other studies and probably reflects the effect of
the acute phase response on ferritin levels.
7 Witte et al
18
developed a nomogram describing the relationship between
ferritin and CRP or erythrocyte sedimentation rate, to detect or
exclude iron deficiency in patients with anaemia of inflamma-
tion in order to minimise bone marrow examination.
Unfortunately, when this nomogram, which corrected for the
acute phase component of changes in ferritin, was applied in
later studies, it performed poorly.
19
Results from the present study indicates that ferritin and
sTfR are relatively good markers for detecting iron stores
deficiency provided that new cut-off values are applied.
Combining these markers into the TfR-F index may prove to
be a much better tool to detect iron deficiency in children in
these high infection pressure areas. The cut-off values for the
TfR-F index are robust and do not need to be adjusted for
inflammation.
Our study is among the largest and most detailed investiga-
tions into assessment of the iron status in children in this
setting and has generated a unique dataset. However, the fact
that we did not do a healthy population-based study, but
focused on a subgroup of severely anaemic children, may limit
generalisability of our findings, especially in view of the fact
that these children also tend to have other inflammatory
conditions that may affect interpretation of ferritin levels.
Obvious ethical issues, of performing bone marrow investiga-
tions in mild and non-anaemic children, was the main reason
for focusing on this study population. However, these findings
may be a starting point and may provide an improved
knowledge of diagnostic criteria for iron status assessment
that avoids the need to do a bone marrow aspiration, and be of
value for determining therapeutic practice. This is especially
important taken the recent observations that iron supplementa-
tion to iron replete children may be fatal.
3
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Take-home messages
c There is a need to properly diagnose true iron deficiency due
to the probable increased risk of adverse effects associated
with iron supplementation in iron replete individuals.
c Transferrin-ferritin index is probably the most useful and robust
iron marker that best predicts bone marrow iron status.
c Mean cell haemoglobin concentration may be an acceptable
alternative screening test in resource-poor settings.
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